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Cardiac muscle contraction is triggered by calcium binding to troponin.
The consequent movement of tropomyosin permits myosin bind-
ing to actin, generating force. Cardiac myosin-binding protein C
(cMyBP-C) plays a modulatory role in this activation process. One
potential mechanism for the N-terminal domains of cMyBP-C to
achieve this is by binding directly to the actin-thin filament at low
calcium levels to enhance the movement of tropomyosin. To
determine the molecular mechanisms by which cMyBP-C enhances
myosin recruitment to the actin-thin filament, we directly visual-
ized fluorescently labeled cMyBP-C N-terminal fragments and GFP-
labeled myosin molecules binding to suspended actin-thin filaments
in a fluorescence-based single-molecule microscopy assay. Binding
of the C0C3 N-terminal cMyBP-C fragment to the thin filament
enhanced myosin association at low calcium levels. However, at
high calcium levels, C0C3 bound in clusters, blockingmyosin binding.
Dynamic imaging of thin filament-bound Cy3-C0C3 molecules dem-
onstrated that these fragments diffuse along the thin filament
before statically binding, suggesting a mechanism that involves a
weak-binding mode to search for access to the thin filament and a
tight-binding mode to sensitize the thin filament to calcium, thus
enhancing myosin binding. Although shorter N-terminal fragments
(Cy3-C0C1 and Cy3-C0C1f) bound to the thin filaments and displayed
modes of motion on the thin filament similar to that of the Cy3-
C0C3 fragment, the shorter fragments were unable to sensitize the
thin filament. Therefore, the longer N-terminal fragment (C0C3) must
possess the requisite domains needed to bind specifically to the thin
filament in order for the cMyBP-C N terminus to modulate cardiac
contractility.
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Cardiac myosin-binding protein C (cMyBP-C) modulates car-diac contraction at the level of the sarcomere. Mutations in the
cMyBP-C gene are a major cause of hypertrophic cardiomyopathy
(1), a disease that affects up to 1 in 200 people (2) and is the
leading cause of sudden cardiac death in young adults (1, 3).
cMyBP-C is composed of 11 subdomains from C0 to C10 (Fig. 1A),
8 Ig-like and 3 Fn(III)-like with a proline–alanine-rich region be-
tween C0 and C1, and a linker between C1 and C2 (i.e., M-domain)
(4). Each cMyBP-C molecule is tethered through its C terminus (5)
to the myosin thick filament (6), while its N-terminal domains are
free to contact either the myosin head region or the actin thin
filament (7) (Fig. 1A). Specifically, cMyBP-C interactions with
myosin have been shown to occur through the S2 region (8–11),
the myosin regulatory light chain (RLC) (12) and the S1 head
(13), which may serve to stabilize myosin’s superrelaxed state
(14–16) through interactions with the recently defined myosin
mesa region (13, 17). In addition to myosin binding, cMyBP-C
interacts with actin via its N-terminal domains (C0–C2) (18–21).
These binding-partner interactions are believed to functionally
impact cardiac contractility. For example, cMyBP-C knockout
mouse cardiomyocytes (22) demonstrate a decrease in calcium
sensitivity while N-terminal fragments infused into skinned fibers
(11) result in an increase in calcium sensitivity. Accordingly, fluo-
rescence assays in muscle cells (10) have demonstrated that cMyBP-
C N-terminal fragments activate muscle at low calcium levels and
inhibit maximal activity at high calcium, suggesting dual roles in
modulating contraction in vivo.
Mechanistically, muscle activation occurs by calcium-dependent
shifts in the position of tropomyosin on the thin filament (23, 24).
Tropomyosin binds axially along the thin filament (Fig. 1A) and
shifts azimuthally when calcium binds to the tropomyosin-associated
troponin protein complex. Three positions of tropomyosin have
been structurally (24) and functionally (25) defined: blocked
(sterically preventing myosin binding), closed (myosin can bind
weakly), and open (myosin binding is unperturbed). It has been
proposed that the cMyBP-C N terminus could sensitize the thin
filament to calcium through the displacement of tropomyosin
from its blocked to its closed position, to enhance myosin binding
(21). The function of the cMyBP-C N-terminal subdomains
C0C3, C0C1, and C0C1f (i.e., C0C1 including the first 17 M-domain
residues) have been extensively characterized for their ability to
sensitize the thin filament to calcium using in vitro motility (18,
26, 27), ATPase assays (19), and electron micrographic studies
(18, 21, 28). Our previous studies and that of others show that all
three bind to actin, but only the C0C3 fragment can both activate
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thin filament sliding at low (0.1 μM) calcium and inhibit sliding
at high (100 μM) calcium levels. In contrast, the shortest fragment,
the murine C0C1, does neither, while the C0C1f with its additional
17 residues of the M-domain can only inhibit thin filament sliding
at high calcium (18). These differential functions may allow as-
signment of specific functional capacities to cMyBP-C’s N-terminal
domains.
To define the molecular basis of thin-filament activation by
cMyBP-C, we used a single-molecule suspended thin filament
assay (Fig. 1B), in which we could directly observe the calcium-
dependent binding of individual fluorescently labeled myosin-S1
molecules to the thin filament (29). Using all three murine cMyBP-
C N-terminal fragments (Fig. 2B), C0C3, C0C1, and C0C1f, we show
that cMyBP-C’s N terminus (C0C3) can maximally activate the
thin filament, permitting myosin-S1 to bind even at low calcium.
However, at high calcium with the thin filament maximally activated
cMyBP-C can decrease myosin-S1 binding. By imaging fluo-
rescently labeled cMyBP-C N-terminal fragments we observed
these molecules individually binding directly to the thin filament.
Once bound, the cMyBP-C fragments both diffuse along the thin
filament and bind statically, with enhanced static binding observed
only for the C0C3 fragment at high calcium levels that maximally
activate the thin filament. These fragment binding and motion
behaviors on the thin filament provide direct mechanistic insight
into how cMyBP-C achieves both calcium sensitization at low calcium
and reduced activation at high calcium, and thus modulation of
cardiac contractility.
Results
The Effect of cMyBP-C N-Terminal Domains on S1-GFP Myosin Binding
to the Thin Filament.We studied how each of the three N-terminal
fragments C0C3, C0C1f, and C0C1 (Fig. 2) affects myosin binding
to thin filaments (18–21), by directly measuring individual S1-GFP
molecules interacting with thin filaments in their presence. Using
1 μM unlabeled cMyBP-C N-terminal fragments, we determined
the level of S1-GFP (15 nM) binding to the thin filament at low
and high calcium (0.1 μM and 100 μM, respectively). The frag-
ment concentration was chosen based on past motility studies in
which 1 μMC0C3 both sensitized the thin filament to calcium and
inhibited thin filament motility at maximally activating calcium
concentrations (30). Fig. 2A shows representative kymographs for
S1-GFP binding. At low calcium in the absence of C0C3, the
kymograph (Fig. 2A, Upper Left) shows very few S1-GFP binding
events, consistent with the thin filament’s not being fully activated,
as previously described (29). At high calcium in the absence of
C0C3, the thin filament is activated, as evidenced by significant
S1-GFP binding to the thin filament (Fig. 2A, Upper Right). In the
presence of C0C3 the situation is reversed. At low calcium, con-
siderable S1-GFP binding is observed (Fig. 2A, Lower Left), whereas
at high calcium these interactions are rare (Fig. 2A, Lower Right). To
quantify changes in S1-GFP binding, we calculated the mean
fluorescence intensity per pixel for each tightrope. Minimally,
10 tightropes were observed under the same experimental condi-
tion (Fig. 2B). To compare the effects of a given cMyBP-C frag-
ment on S1-GFP binding, the average fluorescence intensity per
pixel was normalized to that at low calcium concentration in the
absence of fragments (Fig. 2B). At low calcium, addition of C0C3
significantly increased S1-GFP binding [57.0 ± 7.6% (SEM)] vs. no
fragment, equivalent to that observed at high calcium in the ab-
sence of C0C3 [55.7 ± 13.2% (SEM)]. However, addition of C0C3
at high calcium also significantly reduced S1-GFP binding by
38.3 ± 15.8% (SEM) vs. the absence of C0C3 at high calcium.
Interestingly, no significant difference in S1-GFP binding was
seen as a result of the introduction of either shorter fragment,
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Fig. 1. Thin filaments in vivo and in the single-molecule tightrope assay. (A) The subdomain structure of cMyBP-C and its spatial relationship to the thin
filament (actin decorated with tropomyosin and the troponin complex TnT, TnI, and TnC) and myosin-containing thick filament in the sarcomere. (B) The thin-
filament tightrope assay. Regulated thin filaments are suspended between surface-adhered beads using a microfluidic device and visualized using a high-N.A.
objective lens. (C) A regulated thin filament labeled with AF633-phalloidin can be visualized suspended between two beads. (D) Representative kymograph of
interactions between 15 nM S1-GFP and a thin-filament tightrope at high calcium (pCa 4) and 0.1 μM ATP. Each x-axis pixel corresponds to a frame (300 ms),
and each pixel on the y axis corresponds to 126.4 nm along the tightrope.
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C0C1f or C0C1, at both low and high calcium. These results
suggest that the shorter fragments are missing critical domains
essential for modulating S1-GFP binding to the thin filament in
a calcium-dependent manner.
Imaging N-Terminal cMyBP-C Fragments Binding to the Thin Filament.
As described above, only the C0C3 fragment affected S1-GFP
binding to the thin filament in a calcium-dependent manner.
Could the differential effects seen for the C0C3 fragment compared
with the shorter C0C1f and C0C1 fragments be related to a dif-
ference in their binding to the thin filament? Therefore, we imaged
20 nM Cy3-tagged C0C3, C0C1f, and C0C1 interacting with thin
filaments at both low and high calcium. Fig. 3 shows clear binding
of all three fragments to the thin filaments using long-exposure
(1 s) still images. These images were analyzed to determine the
average number of fragment molecules bound per micrometer of
thin filament. To ensure a more accurate determination of closely
spaced fluorescent fragments that could not be spatially resolved,
we used fluorescent spot intensity to estimate the number of mol-
ecules per spot. First, we determined the fluorescence intensity for
single Cy3-C0C3 molecules from thin filament binding images at
low calcium (Fig. 3A, Left), where fluorescent spots were easily
discernible. Even in these conditions there was considerable
variance in spot intensity, suggesting that such spots were due to
closely spaced, neighboring Cy3-C0C3 molecules. To extract the
fluorescent intensity of a single molecule, we fitted the distribution
of intensities at low calcium to multiple Gaussians (29, 31) as
detailed in SI Appendix, Fig. S1. Using the fluorescence intensity of
a single Cy3, we converted each fluorescence spot intensity along a
tightrope into the number of bound molecules and used this to
calculate the average number of cMyBP-C fragments bound per
micrometer of thin filament. For Cy3-C0C3 (Fig. 3 A and D), there
was a significant greater than fivefold increase in binding at high vs.
low calcium [6.27 ± 1.15 molecules per μm (SEM, n = 2) vs. 0.84 ±
0.17 molecules per μm (SEM, n = 11), respectively]. This was not
the case for Cy3-C0C1f (Fig. 3 B and D), where no significant (P =
0.55) change in decoration of thin filaments (in molecules per μm)
was observed between low and high calcium [1.17 ± 0.21 (SEM,
n = 9) vs. 1.56 ± 0.77 (SEM, n = 5) molecules per μm, respec-
tively]. However, significantly more Cy3-C0C1 (Fig. 3 C and D)
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Fig. 2. The calcium-dependent effects of cMyBP-C fragments on S1-GFP binding to regulated thin filaments. (A) Representative kymographs of S1-GFP
binding to thin filaments in the absence and presence of C0C3, at low and high calcium, collected at 3.3 fps. (B) Bar chart of the average intensity/pixel ratio in
the kymographs of S1-GFP binding in the absence and presence of different cMyBP-C N-terminal fragments; the values have been normalized to each re-
spective control experiment (i.e., no fragment present at low [Ca2+]). Data were collected using 15 nM S1-GFP with or without 1 μM of fragment, with n values
representing the number of tightropes imaged per condition. The number of experimental repeats (flowcells) is shown at the bottom of the bars. Results
showed a significant increase [57.0 ± 7.6% (SEM)] in S1-GFP binding in the presence of C0C3 at low calcium and reduction [38.3 ± 15.8% (SEM)] at high
calcium; no significant difference was seen when using the shorter fragment C0C1f [14.4 ± 15.3% (SEM), P = 0.42 at low calcium and 13.4 ± 16.9% (SEM), P =
0.42 at high calcium] and C0C1 at low [−4.3 ± 10.3% (SEM), P = 0.70] and high calcium [−13.4 ± 18.0% (SEM), P = 0.44]. *Significant at P < 0.075.
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bound to thin filaments at low [2.57 ± 0.45 (SEM, n = 7) molecules
per μm] vs. high calcium [0.85 ± 0.51 (SEM, n = 4) molecules per
μm]. In summary, only C0C3 binding to the thin filament was
substantially affected by calcium, resulting in increased binding at
high calcium.
At high calcium, the binding of Cy3-C0C3 did not occur uni-
formly across thin filaments; instead, binding occurred in clusters
(Fig. 3 and SI Appendix, Fig. S2), suggesting the possible exis-
tence of coordinated binding. To quantify this, we determined
the number of molecules per fluorescent spot for Cy3-C0C3, the
only fragment that showed increased binding at high calcium.
Fig. 4 shows the distribution of number of molecules within each
fluorescent spot or cluster on a thin filament for Cy3-C0C3 at
low and high calcium. At low calcium, the majority of fluorescent
spots contain only a single Cy3-C0C3; however, at high calcium
the distribution is quite broad with its peak at four Cy3-C0C3
molecules per spot. To investigate the nature of these distributions
we first tried fitting the high-calcium data to a Poisson distribution.
The fit as shown in Fig. 4 (dotted line) does not adequately de-
scribe the data; however, the Poisson distribution has a peak value
of 5.2, which suggests that Cy3-C0C3 is binding in clusters. For a
more meaningful fit of Cy3-C0C3 binding, we used the mechanistic
explanation of myosin binding to a calcium-regulated thin filament,
which is based upon the accessibility of actin binding sites afforded
by motions of tropomyosin across the thin filament (25). We pro-
pose that tropomyosin movements from the blocked to the closed
state that occur either transiently or through calcium induction re-
sult in the exposure of cMyBP-C binding sites. Thus, upon Cy3-
C0C3 binding, Cy3-C0C3 could stabilize the closed state, and be-
cause of the inherent stiffness of tropomyosin (32) this would expose
more cMyBP-C binding sites locally on the thin filament. This
mechanism is analogous to that of thin-filament activation by rigor
myosin binding (33, 34). Therefore, here we utilized the model we
described previously to explain the calcium-dependent activation
of the thin filament (29) to fit Cy3-C0C3 binding data in Fig. 4.
In brief, the model of Cy3-C0C3 binding to the thin filament
(i.e., actin), which can adopt different states of activation, can be
summarized by the following chemical equilibrium:
AB +Ca2+↔
KCa ACl +M↔
K2 ACl.M.
AB is actin in the blocked state, ACl is actin in the closed state and
able to bind cMyBP-C (M), and ACl.M is actin in the closed state
able to bind to d molecules of M. The probability of M being
attached to the thin filament (probatt) is given by the ratio of time
spent attached (τon) vs. the sum of τon and the time spent de-
tached (τoff):
probatt =
τon
τon + τoff
,
where τon is a measured parameter (SI Appendix, Fig. S3). τoff
depends on the proportion of thin filaments in the ACl.M state
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Fig. 3. Fluorescent cMyBP-C N-terminal fragments associate with thin filament tightropes. Representative images of tightropes decorated using 20 nM Cy3-
tagged (A) C0C3, (B) C0C1f, and (C) C0C1, in low and high calcium conditions. (D) Bar chart indicating the average number ± SEM of Cy3-tagged N-terminal
cMyBP-C fragments bound per micrometer micrometer of tightrope. n = number of tightropes imaged, above and within the bars are flowcell numbers.
*Significant at P < 0.075. Further examples of clustered binding are shown in SI Appendix, Fig. S2.
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(pACl.M; see SI Appendix for mathematical description) and be-
cause Cy3-C0C3 binding results in the exposure of more sites on
actin, this allows more (i.e., d) Cy3-C0C3 to bind in an effective
cooperative unit. Therefore, τoff is expressed as follows:
τoff = 1
.
ðd · pACl.MÞ.
As in Desai et al. (29), the probability of the exact number (n) of
cMyBP-C molecules binding is probatt
n × (1 − probatt)n, and this
equation was used for fitting (Fig. 4).
Fig. 4 shows the fit to the probability of the exact number of
Cy3-C0C3 binding performed by the Microsoft Excel GRG
Nonlinear fitting engine to globally fit the high and low calcium
conditions simultaneously. The affinity (Kca) of calcium binding
to thin filaments was fixed at 0.7 μM (pCa50 of ∼6.15) based on
previous studies (29, 35). Since the size of the cooperative unit is
a property of tropomyosin’s stiffness, we also fixed the size of the
cooperative unit (d) at 11, as previously determined (29). τon was
measured at high calcium as 5.1 (±3.1 >95% CI) s (SI Appendix,
Fig. S3). The only fitted parameter K2, the affinity of Cy3-C0C3
for the ACl.M state of the thin filament, was found to be 0.18
(±0.02; >95% CI) μM.
N-Terminal cMyBP-C Fragments Display Two Modes of Motion on Thin
Filaments.Dynamic imaging of cMyBP-C fragments on thin filament
tightropes unexpectedly revealed that in addition to N-terminal
fragments binding statically to thin filaments [Fig. 5A, horizontal
trace (arrowhead)] a proportion of the fragments appeared to
diffuse randomly along the thin filament [Fig. 5A, trace with
y-axis movement (star)]. Statically bound molecules were defined
as not showing any apparent movement greater than one pixel in
both dimensions (equivalent to 120 nm and 1 s) during the entire
detection time window of >200 s [Fig. 5A, horizontal trace (arrow-
head)]. This behavior was calcium-dependent for Cy3-C0C3
molecules; the proportion of kymograph traces showing dif-
fusive Cy3-C0C3 motion decreased significantly (P < 0.075)
from 19.4 ± 4.6% (SEM, n = 11) at low calcium to 6.0 ± 1.8%
(SEM, n = 8) at high calcium (Fig. 5B). By comparison, Cy3-C0C1f
showed no significant difference (P = 0.203) in the proportion of
diffusive molecules at both low and high calcium, 27.3 ± 2.2%
(SEM, n = 9) and 32.3 ± 3.1% (SEM, n = 6), respectively. This
was also the case for Cy3-C0C1 24.5 ± 6.4% (SEM, n = 7) vs.
47.7 ± 26.2% (SEM, n = 3) at low and high calcium, respectively
(P = 0.2542). We also observed that some of the diffusing mole-
cules would switch to static binding during their interaction
with the thin filament (SI Appendix, Fig. S4), which was interpreted
as being temporarily bound to a specific site in a partially exposed
region of the thin filament; nonetheless, these molecules were
classified as diffusive.
We calculated the diffusional characteristics summarized in SI
Appendix, Table S1 using mean squared displacement (MSD):
MSD=
1
n
Xn
i=1
ðxiðtÞ− xið0ÞÞ2 = 2Dtα,
where D is the diffusion constant of the molecule, t is the analysis
time window, xiðtÞ is the position at time t, xið0Þ is the starting
reference position, and α is a coefficient that denotes the nature
of the diffusion, where values close to 1 indicate random diffu-
sion (36). Diffusion constants were transformed to log values
before averaging and errors propagated to real numbers to pro-
vide the values in SI Appendix, Table S1.
Diffusion along a lattice can be described as multiple discrete
steps with an average stepping rate. This definition allows us to
calculate the average step size of the fragments on the thin fil-
ament, provided the stepping rate is known. We can calculate the
stepping rate from attached lifetimes obtained from laser trap
studies (37) that indicated C0C3, C0C1f, and C0C1 attach with
two lifetime populations, <30 ms and >200 ms. Given that the
longer events were ∼60 times less frequently observed, and more
likely to represent the a population of the stronger interactions
that we report here (SI Appendix, Fig. S3), we used the short
lifetime to calculate the step size for each fragment at low cal-
cium, according to the equations below (38):
stepping rate=
1
τ
=
2D
l2
∴ step size= l=
ﬃﬃﬃﬃﬃﬃﬃﬃ
2Dτ
p
,
where τ is the attached lifetime, D is the diffusion constant, and l
is the average step size. This provides an average step size of
17 ± 3 nm (SD) for Cy3-C0C3, 12 ± 2 nm (SD) for Cy3-C0C1f,
and 7 ± 1 nm (SD) for Cy3-C0C1. Due to the method of calcu-
lating these values it was not possible to generate a significance
test; therefore, these values provide a range of step size from
approximately one to three actin monomers.
Discussion
cMyBP-C plays a critical role in modulating cardiac contractility
(39, 40), as evidenced by the high prevalence of cMyBP-C mu-
tations in hypertrophic cardiomyopathy (41). One way for
cMyBP-C to modulate cardiac contractility is to alter the sensi-
tivity of the thin filament to calcium (10, 18, 27, 39), as reported
here. To determine the underlying mechanism by which cMyBP-
C enhances thin-filament activation at low calcium levels (18,
26), we directly visualized the impact of cMyBP-C N-terminal
fragments on the binding of individual myosin (S1-GFP) mole-
cules along a single suspended actin-thin filament. Specifically,
we observed that the C0C3 N-terminal fragment enhanced myosin
binding to thin filaments at low calcium (i.e., increased calcium
sensitivity) and reduced myosin binding at high calcium. These
results are consistent with our previous in vitro motility studies
and that of others (18, 26), showing that cMyBP-C’s N terminus
is sufficient to sensitize the thin filament to calcium and to modulate
thin-filament sliding velocities at high calcium. The binding of
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Fig. 4. Histogram of cMyBP-C cluster sizes. The percent occurrence of
fluorescent molecules bound to the thin-filament tightropes in clusters was
determined based on the fluorescence intensity of a single Cy3-C0C3 (SI
Appendix, Fig. S1). Plotted at low calcium (solid bars) and high calcium
(dotted bars), data are fitted to the relationship shown in the main text. A
best-fit Poisson distribution is shown with the dotted curve. The sum square
differences of the Poisson vs. chemical kinetic model are 14.8 and 1.92, re-
spectively, for the high-calcium dataset.
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Cy3-C0C3 itself to the thin filament is seen to occur in clusters
and this binding most likely displaces tropomyosin to a position
that facilitates myosin binding (10, 18, 20). Surprisingly, ∼20%
of total Cy3-C0C3 binding events show diffusive behavior on the
thin filament at low calcium, which may reflect the behavior of
cMyBP-C’s N terminus within the sarcomere as it searches for its
binding site on the thin filament.
Specific cMyBP-C N-Terminal Domains Are Necessary for Thin-Filament
Activation.Activation of the thin filament at high calcium triggered
significant S1-GFP binding, as expected (Fig. 2). Interestingly, the
C0C3 N-terminal fragment sensitized the thin filament to calcium
so that at low calcium, S1-GFP binding was equivalent to that for a
fully calcium-activated thin filament (Fig. 2). The shorter N-terminal
fragments (C0C1f and C0C1), with the C2 and C3 domains and a
portion or the entire M-domain removed, were still capable of
binding to thin filaments (Fig. 3). However, these fragments failed
to sensitize the thin filament at low calcium (Fig. 2), measured as
no change in S1-GFP binding in their presence. The failure of
these shorter, murine cMyBP-C N-terminal fragments to sensitize
the thin filament agrees with ATPase (19), in vitro motility (18,
26), and fragment-infused fiber data (11), suggesting that murine
N-terminal fragments require at least C0–C2 to observe maximal
thin filament calcium sensitization compared with the human N-
terminal cMyBP-C fragments, where C0C1 and C1 alone are suffi-
cient to sensitize the thin filament to calcium (19, 20, 42, 43). This
species difference has been attributed to alternate sequences in the
Pro-Ala linker between C0 and C1 as well as C1 itself (44).
The three-state model for thin-filament regulation (25) pro-
vides a useful mechanistic context for how C0C3 sensitizes the
thin filament to calcium. Specifically, calcium binding to the thin
filament permits tropomyosin movement on actin to expose
myosin binding sites, shifting tropomyosin from the “blocked” to
the “closed” position. As a result of myosin binding, tropomyosin
is further displaced to the “open” or “myosin” position (24),
therefore propagating the binding of additional myosins (29). By
C0C3 binding to the thin filament at low calcium as it transiently
enters the closed position, this N-terminal fragment may stabilize
tropomyosin in the closed position, allowing myosin binding to
actin, as supported by structural studies of tropomyosin move-
ment caused by C0C2 binding to thin filaments (18). Since our
data show a distinct difference between binding at low and high
calcium concentrations, this may also suggest that additional
binding sites become available once tropomyosin is displaced
from the blocked position. The clustered or possible coordinated
binding of C0C3 most likely represents binding to newly acces-
sible actin adjacent to the location of a previously bound C0C3;
however, intermolecular interactions between C0C3 molecules
may also contribute.
Modes of cMyBP-C N-Terminal Interactions with the Thin Filament.
The modular architecture of cMyBP-C provides the potential to
structurally compartmentalize its functional capacities. Even
though the very N-terminal domains, C0C1 and C0C1f, bind to
actin (20, 21, 45, 46) as we have also shown previously (47), only
C0C3 possesses the ability to sensitize the thin filament to low
calcium while decreasing activation levels at high calcium.
Unique to our study is the observation that upon binding of these
N-terminal fragments to the thin filament, the fragments either
remain stationary or undergo a diffusive-like movement along
the thin filament. Specifically, for C0C3, how do these two dis-
tinct modes of interaction (i.e., 20% diffusing and 80% station-
ary) contribute to the thin-filament sensitization at low calcium?
Multiple sites of N-terminal fragment interactions with the thin
filament have been proposed based on actin cross-linking (48),
fragment binding to actin in the laser trap (37), and electron
microscopy studies (18, 20, 21, 46). At low calcium, tropomyosin
on the thin filament should be in a dynamic equilibrium between
the blocked and closed states (49). Presumably, the stationary
Cy3-C0C3 molecules are stereospecifically bound to the thin
filament through multiple binding sites, which could effectively
shift tropomyosin’s equilibrium position to being predominantly
closed and thus sensitize the thin filament to calcium. At low
calcium the Cy3-C0C1 and Cy3-C0C1f have the same distribution
of diffusing and stationary molecules, and therefore the stationary
fractions are not bound in the same manner as Cy3-C0C3, given
the inability of these shorter fragments to sensitize the thin fila-
ment for myosin binding. As individual Ig-domains, both C0 and
C1 can bind to the thin filament in several different configurations
(20, 42), which is not the case for longer C0C2 and C0C3 frag-
ments (21, 50). These structural studies support our proposal
that the stationary Cy3-C0C3 molecules are the result of multiple
sites of interaction with the thin filament, necessary to achieve
calcium sensitization.
For the 20% of the Cy3-C0C3 fragments that diffuse at low
calcium, we observed transient switching from diffusion to static
binding on thin filaments (SI Appendix, Fig. S4). Such behavior
would suggest that the diffusing molecules were interacting with
regions of the thin filament more stably. However, for those
transient static interactions that did not lead to extended binding
this may suggest incomplete formation of a binding interface
with the thin filament, which would otherwise result in activation
and C0C3 recruitment. When diffusing, C0C3 molecules must
weakly interact with the thin filament with a diffusional step size
that we estimate to be between ∼7 and ∼17 nm, consistent with
one to three actin monomers. This diffusive mode of motion may
allow the N terminus of cMyBP-C to maintain contact with and
scan the thin filament until such time that specific cMyBP-C
binding sites are exposed on actin as tropomyosin undergoes
its dynamic equilibrium between blocked and closed positions on
the thin filament. Once statically bound to these sites, cMyBP-C
may stabilize tropomyosin in the closed position (18, 25). This
may also explain why at high calcium where the thin filament is
predominantly in the closed state (25), Cy3-C0C3 binding to the
thin filament is significantly increased (Fig. 3D) and almost en-
tirely stationary (Fig. 5B) as cMyBP-C binding sites on actin
would be readily exposed.
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Fig. 5. cMyBP-C fragments diffuse on and statically bind to thin-filament
tightropes. (A) An example of a kymograph representing the two types of
interaction seen with cMyBP-C (using Cy3-C0C3 as an example). Diffusion on
the thin-filament tightrope is indicated by a star and a stationary molecule is
indicated with an arrowhead. (B) A bar chart providing the mean fraction ±
SEM of diffusing molecules measured at low and high calcium concentra-
tions. n values refer to the number of flowcells. *Significant at P < 0.075.
Data were collected for 200 s or more using 20 nM of either C0C3, C0C1f, and
C0C1 at low calcium; at high calcium, to compensate for decoration levels
that enable individual molecules to be distinguished, 5 nM C0C3 and C0C1f
or 20 nM C0C1 was used.
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The clustering of C0C3 may compete with myosin for actin
binding sites, as proposed in structural studies (18, 20, 21, 46)
and cosedimentation competition studies (51), explaining the
reduction in myosin binding observed on tightropes at high cal-
cium (Fig. 2). Therefore, competitive inhibition of myosin
binding by the N terminus of cMyBP-C may be one contributing
factor to the reduced thin-filament velocity observed both in the
C-zone of native thick filaments (52) and in the motility assay at
high calcium (18, 26). However, reduced cross-bridge numbers in
limited locations on the thin filament may not be enough to slow
motility. It is possible that cMyBP-C binding to the thin filament
may provide a load against which the remaining cross-bridges
work, in turn slowing velocity (53, 54). Is in vivo clustering of
cMyBP-C on the thin filament possible? cMyBP-C is positioned
every ∼43 nm along the thick filament within the C-zone. Since
each thin filament in the muscle lattice is surrounded by three
thick filaments, the individual cMyBP-C N termini from these
thick filaments could cluster at a common point on the thin fila-
ment. In addition, HCM mutations of MyBP-C are known to lead
to truncations (55), which could potentially compete with myosin
as previously suggested (22). Fluorescence detection of Cy3-C0C3
binding and clustering at low vs. high calcium enabled us to fit the
data by a chemical equilibrium model to estimate the affinity of
these cMyBP-C fragments for thin filaments as 0.18 μM. This value
is ∼10-fold tighter than the ∼2 μM reported for unregulated actin
from ATPase inhibition studies (19) and up to 25-fold tighter than
the affinities reported for mouse C0C2 using actin cosedimentation
assays (48, 56). Some studies reporting the lower binding affin-
ities (48) used bare actin, whereas thin filaments were used in the
present study. Recent findings suggest that tropomyosin may
bind cMyBP-C’s N terminus (57); therefore, tropomyosin itself
could act as a cofactor in the clustered binding of C0C3.
Conclusion
In this paper we addressed the nature of thin-filament activation/
inhibition by the N terminus of cMyBP-C. Using a newly de-
veloped single-molecule imaging assay, we propose a mechanism
by which cMyBP-C interacts with thin filaments using two different
binding regimes in relaxing and activating calcium conditions. At
low calcium (relaxing conditions), cMyBP-C senses the thin fila-
ment for changes in activation state due to positional fluctuations
of tropomyosin. Sensing occurs by a weak binding mode in which
the N terminus diffuses from actin monomer to monomer. Once
specific cMyBP-C binding sites are encountered that allow sub-
domains C0 through C3 to bind more tightly, cMyBP-C can then
effectively shift the tropomyosin equilibrium position from the
blocked to the closed state, activating the thin filament. At high
calcium (activating conditions), where calcium binding to troponin
itself shifts tropomyosin from the blocked to the closed position,
cMyBP-C can bind tightly to the thin filament and compete for
myosin binding. It is important to note that our studies define the
cMyBP-C N-terminal interactions with the thin filament but do not
rule out potential interactions with the myosin head region as con-
tributing to the thin filament sensitization. Regardless, our studies
provide at least one molecular model for how cMyBP-C carries out
its function within the confines of the sarcomere in vivo.
Materials and Methods
Protein Purification. Actin and myosin were purified from chicken pectoralis
muscle (58), and recombinant human cardiac tropomyosin and troponin
were expressed in Escherichia coli and further purified as described pre-
viously (59). Murine cMyBP-C fragments were bacterially expressed with a
C-terminal His-tag for purification using a nickel affinity column. Myosin-
S1 was produced from whole myosin by papain digestion (60) and labeled
with EGFP by exchange of the endogenous RLC with recombinantly ex-
pressed EGFP-tagged RLC (29); this construct is termed S1-GFP. Using the
proteolytically derived single-headed S1 construct, instead of full-length
myosin or heavy meromyosin, simplified interpretation and quantification
of the data. Thin filaments were fully reconstituted by incubating actin,
tropomyosin, and troponin overnight at 4 °C in 4 mM imidazole, pH 7, 2 mM
MgCl2, 1 mM DTT, and 0.5 mM ATP (61) with a molar ratio actin: tropomyosin:
troponin of 2:0.5:0.25. In all experiments, thin filaments were labeled with
AF633-phalloidin (A22284; Invitrogen) for imaging in the flow chamber. For
experiments involving cMyBP-C N-terminal fragments binding to thin fila-
ments, the N-terminal fragments (i.e., C0C3, C0C1f, and C0C1; see Fig. 2B) were
fluorescently labeled with a maleimide-Cy3 (PA23031; GE Healthcare) as in
ref. 62, achieving ∼30% labeling efficiency. Based on the C0C3 structure, there
is only one surface-exposed reactive cysteine (C248) and thus only one Cy3 dye
per labeled N-terminal fragment (62).
The Thin-Filament Tightrope Assay. To nullify any potential surface interfer-
ence and to permit full, 3D accessibility to all myosin and cMyBP-C binding
sites on the thin filament, we suspended thin filaments between surface-
adhered beads to create tightropes (Fig. 1B) as described in detail previously
(29). Briefly, silica beads were functionalized with 340 μg/mL poly-L-lysine
and adhered to a glass coverslip by infusion into a microfluidic flow cell. To
generate tightropes, 500-nM thin filaments were passed across the silica
beads multiple times back and forth using a syringe pump. Imaging was
performed using a custom-built oblique angle fluorescence microscope (38)
that excites the sample with a continuous-wave 20-mW, 488-nm DPSS laser
(JDSU) focused off-center at the back-focal plane of a 100× objective (1.45 N.A.)
to achieve obliquely angled illumination. We detected images (Fig. 1C) through
an Optosplit III (Cairn Research) projected onto a Hamamatsu OrcaFlash
4.2 camera.
Data Collection and Analysis. All experiments were performed in either high
(100 μM, pCa 4) or low (0.1 μM, pCa 7) calcium buffers of 25 mM imidazole,
pH 7.4, 4 mM MgCl2, 1 mM EGTA, and KCl adjusted to a final ionic strength
of 51 mM using MaxChelator (63). Ten or more tightropes were imaged per
condition (details of the conditions are provided in Results). Videos of S1-GFP
binding to thin filaments were acquired at three frames per second (fps) for
up to 1 min, while videos of Cy3-labeled cMyBP-C fragments were acquired
at 1 fps for up to 5 min. To determine the spatial and temporal dynamics of
S1-GFP or Cy3-labeled cMyBP-C fragments interacting with thin filaments,
we transformed movies into kymographs where fluorophore position was
plotted along the y axis and time on the x axis (Fig. 1D). Analysis of bound
fluorophore position was performed using custom-written macros in ImageJ
available online (kadlab.mechanicsanddynamics.com). To measure the ex-
tent of S1-GFP binding we integrated the fluorescence intensity over the
entire kymograph and normalized to the total number of pixels. All statis-
tical P values mentioned were calculated using an unpaired t test, and P
values <0.075 were considered significant. All SEM values were calculated
using the number of flowcells, and in the case of comparative calculations
SEM is a propagated error and therefore no n value is given. For data fitted
using Microsoft Excel, the >95% CI values were calculated using the method
of Kemmer and Keller (64).
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